NervGen Pharma Corp. (NGEN) — Long-term Investment Intensity

Latest as of December 2024: 0.1%

NervGen Pharma Corp. (NGEN) has a Long-term Investment Intensity of 0.1% as of December 2024. Long-term investments of $8.37K represent 0.1% of total assets of $13.54 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See NervGen Pharma Corp. (NGEN) net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

0.1%
LT Investments / Total Assets

Long-term Investments

$8.37K
USD

Total Assets

$13.54 Million
USD

Country

USA
NASDAQ

NervGen Pharma Corp. Long-term Investment Intensity (2024–2024)

This chart shows how NervGen Pharma Corp.'s Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the intensity stands at 0.1%, reflecting long-term investments of $8.37K against total assets of $13.54 Million USD. Also explore NervGen Pharma Corp. balance sheet assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for NervGen Pharma Corp. (2024–2024)

The table below presents the year-by-year Long-term Investment Intensity for NervGen Pharma Corp. from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NervGen Pharma Corp. market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2024 0.1% $8.37K $13.54 Million
pp = percentage points